Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajat Kumar

Showing results (291-300 of 341) with videos related to

Pageof 35
Sort By:
Transplantation and Cellular Therapy|February 9, 2022
Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center ExperienceMaria Queralt Salas, Ivan Pasic, Mats Remberger, et al.
Transplantation and Cellular Therapy|April 22, 2024
Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort StudyIvan Pasic, Tommy Alfaro Moya, Mats Remberger, et al.
European Journal of Haematology|September 25, 2019
Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantationMaria Queralt Salas, Eshetu G Atenafu, Maria Rhida Bautista, et al.
Hematology/Oncology and Stem Cell Therapy|December 2, 2021
Outcomes of Patients Diagnosed With Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Tertiary Care CenterSwe M Linn, Ram V Nampoothiri, Carol Chen, et al.
British Journal of Haematology|July 19, 2025
Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantationNihar Desai, Eshrak Al-Shaibani, Tommy Alfaro-Moya, et al.
Frontiers in Nutrition|January 28, 2026
Dietary diversity and its associated factors among rural labourers in South IndiaSettipalli Sravani, V Lenin, Pratibha Joshi, et al.
Transplantation and Cellular Therapy|October 17, 2021
Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center StudyAbel Santos Carreira, Maria Queralt Salas, Mats Remberger, et al.
Bone Marrow Transplantation|June 3, 2025
Prolonged length of stay in high-risk patients undergoing allogeneic stem cell transplantation: a call to action for addressing healthcare challengesAyman Sayyed, Igor Novitzky-Basso, Mats Remberger, et al.
Cancers|February 26, 2025
Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell TransplantationElizabeth Herrity, Sanjay Singhabahu, Mats Remberger, et al.
European Journal of Haematology|June 30, 2020
Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplantRehab Alblooshi, Solaf Kanfar, Bridgette Lord, et al.
Pageof 35

Showing results (291-300 of 341) with videos related to

Sort By:
Pageof 35
Transplantation and Cellular Therapy|February 9, 2022
Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center ExperienceMaria Queralt Salas, Ivan Pasic, Mats Remberger, et al.
Transplantation and Cellular Therapy|April 22, 2024
Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort StudyIvan Pasic, Tommy Alfaro Moya, Mats Remberger, et al.
European Journal of Haematology|September 25, 2019
Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantationMaria Queralt Salas, Eshetu G Atenafu, Maria Rhida Bautista, et al.
Hematology/Oncology and Stem Cell Therapy|December 2, 2021
Outcomes of Patients Diagnosed With Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Tertiary Care CenterSwe M Linn, Ram V Nampoothiri, Carol Chen, et al.
British Journal of Haematology|July 19, 2025
Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantationNihar Desai, Eshrak Al-Shaibani, Tommy Alfaro-Moya, et al.
Frontiers in Nutrition|January 28, 2026
Dietary diversity and its associated factors among rural labourers in South IndiaSettipalli Sravani, V Lenin, Pratibha Joshi, et al.
Transplantation and Cellular Therapy|October 17, 2021
Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center StudyAbel Santos Carreira, Maria Queralt Salas, Mats Remberger, et al.
Bone Marrow Transplantation|June 3, 2025
Prolonged length of stay in high-risk patients undergoing allogeneic stem cell transplantation: a call to action for addressing healthcare challengesAyman Sayyed, Igor Novitzky-Basso, Mats Remberger, et al.
Cancers|February 26, 2025
Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell TransplantationElizabeth Herrity, Sanjay Singhabahu, Mats Remberger, et al.
European Journal of Haematology|June 30, 2020
Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplantRehab Alblooshi, Solaf Kanfar, Bridgette Lord, et al.
Pageof 35